Ablation Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, Hydrothermal, Cryoablation, Hydromechanical Ablation) By Application (Cardiovascular, Cancer, Pain Management, Orthopaedics) By Function (Automated/Robotic and Conventional Ablation Devices) By Procedure (Benign Prostatic Hyperplasia, Transurethral Needle Ablation, Laser and Other Therapies, Atrial Fibrillation, Others) and Region Forecast 2020-2031

Ablation Devices Market size was valued at US$ 10.2 billion in 2024 and is expected to reach US$ 18.5 billion by 2031, growing at a significant CAGR of 8.9% from 2025-2031. Ablation refers to the medical procedure of removing or destroying abnormal tissue, such as tumors or problematic cells, through the application of various energy sources. Ablation devices are specialized medical tools designed to deliver controlled energy, such as heat, radiofrequency, laser, or cold, to precisely target and treat specific areas within the body. These devices are used in a wide range of medical specialties, including cardiology, oncology, dermatology, and more, to treat conditions such as arrhythmias, cancers, and chronic pain. The growing global burden of chronic diseases coupled with the aging global population and increasing need for effective treatment options for chronic diseases play a significant role in driving the growth of the ablation devices market.

According to the World Health Organization, Non-communicable diseases (NCDs) or chronic disorders such as cardiovascular diseases, cancer, and chronic pain conditions are responsible for 41 million deaths worldwide each year, which is 74% of all deaths. Additionally, the adoption of minimally invasive procedures using ablation devices has a substantial impact on increasing the revenues of the ablation devices market. Patients are increasingly seeking treatments that offer quicker recovery times, reduced pain, and shorter hospital stays, which has led to the popularity of minimally invasive techniques.

However, Ablation devices often involve significant upfront costs for healthcare facilities. This includes the cost of the devices themselves, as well as any necessary accessories, training, and maintenance. These high initial costs can be a barrier to the adoption of ablation devices for some healthcare providers. Meanwhile, Advancements in medical technology can lead to the creation of more precise ablation devices with real-time monitoring capabilities and improved patient outcomes. These developments also create opportunities for increased sales. Many manufacturers are working on creating innovative solutions specifically for the healthcare industry. For instance, in May 2023, Abbott received FDA approval for TactiFlex Ablation Catheter, a Sensor Enabled for the treatment of abnormal heart rhythm.

Key Developments:    

• In August 2022, Abbott launched TactiFlex SE radiofrequency ablation catheter in Japan.
• In August 2022, Medtronic plc acquired Affera, Inc. to expand its cardiac ablation portfolio.